Search results for

Let's celebrate Groundhog Day, in all its bizarre, quirky strangeness. Let it remind us that we have not subdued nature, but merely made ourselves more comfortable in its domain.

NPR's Mary Louise Kelly talks with veteran Republican communications strategist Alice Stewart about how Republicans are preparing for the first GOP debate for the 2024 election.

Military lawyers question Pentagon head Pete Hegseth's defense that he didn't share anything revealing in Signal chat group with his wife and brother.

Nevada's U.S. Senate race will be closely watched this year. One voting group critical in the outcome is nonpartisan voters, who make up more than 30 percent of the state's registered voters.

Clinton is the first woman ever to head a major-party ticket in this country. She now has the 2,383 delegate commitments necessary to become the presumptive nominee, according to The Associated Press.

He's the child of Pakistani immigrants, the son of a bus driver, a human rights lawyer — and London's first Muslim mayor. Sadiq Khan's election flies in the face of rising anti-Muslim and anti-migrant sentiment, and folks in his southeast London neighborhood are thrilled. His next test will be trying to push through his ambitious platform of affordable housing and better public transport in a time of spending cuts.

Climate change and overfishing are making it harder to catch the anchovies essential to the condiment that underlies so much of Vietnam and southeast Asia's food.

Trump attorney Michael Cohen is set to go before a federal judge on Wednesday in the latest hearing in the federal criminal case against him in New York. Cohen has been the subject of a months-long investigation into his businesses, which included selling offers of access to Trump.

Critics warn that despite President Trump's call to end the purported weaponization of the Justice Department, it has become more politicized in the president's first three months back in office.

The Trump administration canceled about $500 million for research into mRNA vaccines. The move slows progress in using the technology to prevent a future pandemic or treat disease, experts say.